|
Predisposition to severe disease
|
Obesity
|
More severe symptoms of COVID-19; requirement for complex ICU management; poorer clinical outcomes
|
|
Diabetes
|
Increased clinical severity and mortality
|
|
Access to routine medical care
|
COPD
|
Cancellation of smoking cessation clinics
|
|
Cystic fibrosis
|
Decreased access to multidisciplinary care and transplantation
|
|
Cancer
|
Necessity to defer chemotherapy in some cases
|
|
Chronic kidney disease
|
Infection risk in dialysis units; decreased access to renal transplantation
|
|
Mental health disorders
|
Barriers to accessing outpatient care
|
|
Influence of chronic medications
|
Hypertension
|
Controversy around use of RAAS blockers
|
|
Autoimmune disease
|
Immunosuppressant drugs predispose to infection
|
|
Chronic kidney disease
|
Immunosuppressant drugs predispose to infection
|
|
Negative effects of pandemic lockdown
|
Obesity
|
Restrictions on physical activity; excessive caloric intake
|
|
Mental health disorders
|
Social isolation; heightened anxiety; sleep disturbance; reduced capacity of psychotic patients to adhere to public health advice
|
